ClinicalTrials.Veeva

Menu

Randomized, Double-Blind, Single-Dose, Efficacy and Safety Study of Test Acetaminophen Tablet in Postoperative Dental Pain

McNeil-PPC logo

McNeil-PPC

Status and phase

Completed
Phase 3

Conditions

Post-operative Dental Pain

Treatments

Drug: Test acetaminophen
Drug: Commercial acetaminophen
Drug: Commercial ibuprofen
Drug: Placebo

Study type

Interventional

Funder types

Industry

Identifiers

NCT03224403
CO-170317095828-PACT

Details and patient eligibility

About

To evaluate analgesic onset, efficacy, and safety of 1000 mg acetaminophen administered as two Test Acetaminophen 500 mg tablets (Test ACM) compared with 1000 mg acetaminophen administered as two commercial acetaminophen 500 mg caplets (ACM) and 400 mg ibuprofen administered as two commercial ibuprofen 200 mg liquid-filled capsules (IBU) in the dental pain model following third-molar extractions.

Full description

This is a single-dose, randomized, double-blind, placebo- and active- controlled, parallel-group study to evaluate the analgesic onset, efficacy, and safety profile of Test ACM 1000 mg compared with two commercial products over a four-hour period after third-molar extractions. Subjects will undergo dental extraction of three or four third molars.

Enrollment

664 patients

Sex

All

Ages

17 to 50 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. 17 to 50 years old
  2. Weigh 100 lbs. or greater and have a body mass index (BMI) of 18 to 30 (inclusive)
  3. Dental extraction of three or four third molars
  4. Meets post-surgical pain criteria
  5. Females of childbearing age must be willing to use acceptable method of birth control

Exclusion criteria

  1. Currently pregnant or planning to be pregnant or nursing a baby
  2. Known allergy to acetaminophen, nonsteroidal anti-inflammatory drugs (NSAIDs) including aspirin, as well as hydrocodone or other opioids
  3. Inability to swallow whole large tablets or capsules
  4. Have other conditions that the investigator feels may impact subject's safety and/or the integrity of the study
  5. Use of pain medications 5 or more times per week
  6. Have a history of chronic tranquilizer use, heavy drinking, or substance abuse in the last 5 years
  7. History of endoscopically documented peptic ulcer disease or bleeding disorder in the last 2 years
  8. Have a positive urine drug screen

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

664 participants in 4 patient groups, including a placebo group

Test acetaminophen
Experimental group
Description:
Test acetaminophen 1000 mg dose
Treatment:
Drug: Test acetaminophen
Commercial acetaminophen
Active Comparator group
Description:
Commercial acetaminophen 1000 mg dose
Treatment:
Drug: Commercial acetaminophen
Commercial ibuprofen
Active Comparator group
Description:
Commercial ibuprofen, 400 mg dose
Treatment:
Drug: Commercial ibuprofen
Placebo
Placebo Comparator group
Description:
Placebo
Treatment:
Drug: Placebo

Trial documents
2

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems